BNY Mellon Alcentra Gl C... 주식 가격. DCF - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
BNY Mellon Alcentra Gl Credit Income 2024 Target Term Fund Inc (DCF) 시세

BNY Mellon Alcentra Gl Credit Income 2024 Target Term Fund Inc (DCF)

9.24

0.00

(0.00%)

마감 18 3월 5:00AM

9.24

0.00

( 0.00% )

시간외 단일가: 9:00AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

가격

9.24

매수가

-

매도가

-

거래량

-

0.00 일간 변동폭 0.00

8.42 52주 범위 9.26

전일 종가

9.24

개장가

-

최근 거래 시간

마지막 거래 시간

-

평균 볼륨(3m)

-

재정 규모

-

VWAP

-

Form 40-17F2 - Certificate of accounting of securities in custody of management investment companies [Rule 17f-2]

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Announces Completion of Liquidation

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE: DCF) (the “Fund”) announced today that, in accordance with its...

Form N-CSR/A - Certified Shareholder Report: [Amend]

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Announces Details of Liquidation

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE: DCF) (the “Fund”) announced today additional details concerning the...

Form N-CEN - Annual Report for Registered Investment Companies

Form N-CSR - Certified Shareholder Report

Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE: DCF) declared a distribution of $0.035 per share of common stock...

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. Declares Monthly Distribution

On August 28, 2024, BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc. (NYSE: DCF) declared a distribution of $0.035 per share...

Form N-PX - Annual Report of proxy voting record of management investment companies

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	9.24	9.24	9.24	0	0	CS
4	0	0	9.24	9.24	9.24	0	0	CS
12	0	0	9.24	9.24	9.24	0	0	CS
26	0.04	0.434782608696	9.2	9.26	9.09	12539	9.18411941	CS
52	0.69	8.0701754386	8.55	9.26	8.42	28687	8.88879044	CS
156	1.01	12.2721749696	8.23	9.26	6.68	33658	8.02570907	CS
260	2.31	33.3333333333	6.93	9.99	4.6	33698	8.21721787	CS

DCF - Frequently Asked Questions (FAQ)

What is the current BNY Mellon Alcentra Gl C... share price?

The current share price of BNY Mellon Alcentra Gl C... is US$ 9.24

What is the 1 year trading range for BNY Mellon Alcentra Gl C... share price?

BNY Mellon Alcentra Gl C... has traded in the range of US$ 8.42 to US$ 9.26 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
AKAaka Brands Holding Corp	US$ 16.14 (35.06%)	10
GBTGGlobal Business Travel Group Inc	US$ 9.99 (34.27%)	39
ACELAccel Entertainment Inc	US$ 12.00 (22.20%)	268
ENZEnzo Biochem Inc	US$ 0.5565 (18.38%)	3.84k
GBCIGlacier Bancorp Inc	US$ 52.99 (17.91%)	8
BKKTBakkt Holdings Inc	US$ 8.41 (-34.45%)	97.45k
VELVelocity Financial Inc	US$ 15.01 (-21.62%)	7
JELDJELD WEN Holding Inc	US$ 5.02 (-19.03%)	7
SNDASonida Senior Living	US$ 20.01 (-18.26%)	7
KWKennedy Wilson Holdings Inc	US$ 7.50 (-13.49%)	17
SESSES AI Corporation	US$ 0.6886 (4.68%)	8.44M
QBTSD Wave Quantum Inc	US$ 9.95 (-11.00%)	7.99M
NIONIO Inc	US$ 5.28 (4.97%)	4.91M
BBAIBigBear ai Holdings Inc	US$ 3.2198 (-7.74%)	4.18M
XPEVXPeng Inc	US$ 24.40 (-0.65%)	1M

$7.00 or Nothing

$7.00 or Nothing 2 분 전

Daily Buyout news from HGILS: Japan-based Taiho Pharmaceutical has worked with Araris Biotech since 2023 developing antibody-drug conjugates for the oncology space.
Taiho Pharmaceutical has plunked down $400 million in upfront payments to absorb its research partner, the Swiss oncology compan

Hoskuld

Hoskuld 2 분 전

In OSD, there really is not. There is no challenge to mixing, blending, milling, etc. - very old school stuff that is readily available, well-understood, and easily scalable. This is a good thing that this is no big deal: it is just another reason why this is a good business without complications.

MWM

The ihub app is horrible. Luckily I am usually on the desktop...

KISSINGER

KISSINGER 3 분 전

Understood and wise advice.

art2426

art2426 3 분 전

>>>A shareholders update would be nice.

georgie18

georgie18 3 분 전

UAVS...$1.38...🥳...Off the $1.27Alert...

georgie18

Member Level
Re: georgie18 post# 1545

Monday, March 17, 2025 1:43:05 PM

Post#
1546
of 1546
UAVS...$1.35s clearinge here...🥳

geo

georgie18

georgie18 3 분 전

UAVS...$1.38...🥳...Off the $1.27Alert...

georgie18

Member Level
Re: georgie18 post# 1545

Monday, March 17, 2025 1:43:05 PM

Post#
1546
of 1546
UAVS...$1.35s clearinge here...🥳

geo

georgie18

georgie18 3 분 전

UAVS...$1.38...🥳...Off the $1.27Alert...

georgie18

Member Level
Re: georgie18 post# 1545

Monday, March 17, 2025 1:43:05 PM

Post#
1546
of 1546
UAVS...$1.35s clearinge here...🥳

geo

prototype_101

prototype_101 3 분 전

I've sent in a recommendation for your sainthood to the Vatican, but don't hold your breath

fear & greed game is what cause capitulations, like I told you many times the Shorts will NEVER get a Long capitulation!! In the end it will be the Shorts who capitulate, and the SQUEEZE will b

Chip79

Chip79 4 분 전

For some reason, someone continues to post the same miss-leading information on a daily basis. The real facts are:

>Kevin Lamb does not work for UBQU, he is a VP at Gentell

>Long term debt has grown fom 1.1M in 2023, to 2.4M in 2024. Overall liabilities jumped from 1.6M

Trooperstocks

Trooperstocks 4 분 전

$COEP -COEPTIS forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities. https://seekingalpha.com/pr/20030122-coeptis-therapeutics-secures-worldwide-development-

georgie18

georgie18 4 분 전

AIFF...$5.86...🥳...Off my $3.64 Alert...

georgie18

Member Level
Re: georgie18 post# 90

Monday, March 17, 2025 1:55:42 PM

Post#
91
of 91
AIFF...$5.35...Off my $3.64 Alert...🥳

geor

georgie18

georgie18 4 분 전

AIFF...$5.86...🥳...Off my $3.64 Alert...

georgie18

Member Level
Re: georgie18 post# 90

Monday, March 17, 2025 1:55:42 PM

Post#
91
of 91
AIFF...$5.35...Off my $3.64 Alert...🥳

geor

Trooperstocks

Trooperstocks 4 분 전

$COEP -COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities. https://seekingalpha.com/pr/20030122-coeptis-therapeutics-secures-worldwide-development-and

georgie18

georgie18 4 분 전

AIFF...$5.86...🥳...Off my $3.64 Alert...

georgie18

Member Level
Re: georgie18 post# 90

Monday, March 17, 2025 1:55:42 PM

Post#
91
of 91
AIFF...$5.35...Off my $3.64 Alert...🥳

geor

MightyX

MightyX 5 분 전

“Expect…more groundbreaking content and partnerships in…coming weeks."
https://www.otcmarkets.com/stock/TPTW/news/TPT-Global-Tech-Super-App-Vume-Live-Announces-Global-Live-Streams-of-Sports-News-and-Entertainment-Content?id=470783

monentum2play

monentum2play 6 분 전

didn't type it, just popped up

Slimrico57

Slimrico57 6 분 전

Etrade is not allowing purchase of IJJP ! We need update!!

BigJuan

BigJuan 7 분 전

$HOTH good updates keep dropping...👀

https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-positive-preclinical-results-for-ht-kit-in-aggressive-cancer-gastrointestinal-stromal-tumors-gist-ht-kit-triggered-significant-tumor-cell-death-as-early-as-24-hours-post-t

BigJuan

BigJuan 7 분 전

$HOTH good updates keep dropping...👀

https://www.prnewswire.com/news-releases/hoth-therapeutics-announces-positive-preclinical-results-for-ht-kit-in-aggressive-cancer-gastrointestinal-stromal-tumors-gist-ht-kit-triggered-significant-tumor-cell-death-as-early-as-24-hours-post-t

TooFrank

TooFrank 7 분 전

Evidently the algorithm hasn’t digested the news.

kenjiroo

kenjiroo 7 분 전

in the chat I have asked the question .. I try that again

KVM

Sounds like to me and I could be wrong had to pay their lenders a 1 mil fee to extend deadline for audited Financials and letter from auditors don't have a going concern issue.

BNY Mellon Alcentra Gl C...

Bnp Paribas Easy Equity ...

Jpmorgan Chase Financial...

Quantify Technology

Amundi AIS Index MSCI EM...

Morgan Stanley Finance L...

Elliott Opportunity II

Liberty Funding Pty Ltd ...

Societe Generale Effekten

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관